Sherry A. Weppler

1.0k total citations
11 papers, 836 citations indexed

About

Sherry A. Weppler is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sherry A. Weppler has authored 11 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sherry A. Weppler's work include PI3K/AKT/mTOR signaling in cancer (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Autophagy in Disease and Therapy (2 papers). Sherry A. Weppler is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Autophagy in Disease and Therapy (2 papers). Sherry A. Weppler collaborates with scholars based in Netherlands, Canada and Belgium. Sherry A. Weppler's co-authors include Bradly G. Wouters, Philippe Lambin, Marianne Koritzinsky, Michaël G. Magagnin, Marcel B. Bally, Constantinos Koumenis, Twan van den Beucken, Randal J. Kaufman, Kim G.M. Savelkouls and Josée Dostie and has published in prestigious journals such as The EMBO Journal, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Sherry A. Weppler

11 papers receiving 820 citations

Peers

Sherry A. Weppler
Edwardine Nodzenski United States
G Migneco United Kingdom
Cristovão M. Sousa United States
Shinichi Yabuuchi Japan
Trine Bøttzauw Denmark
Sahithi Pamarthy United States
Arnaud Blomme Belgium
O. Porta Olivares Spain
Catherine Del Vecchio Fitz United States
Bhaswati Sarcar United States
Edwardine Nodzenski United States
Sherry A. Weppler
Citations per year, relative to Sherry A. Weppler Sherry A. Weppler (= 1×) peers Edwardine Nodzenski

Countries citing papers authored by Sherry A. Weppler

Since Specialization
Citations

This map shows the geographic impact of Sherry A. Weppler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry A. Weppler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry A. Weppler more than expected).

Fields of papers citing papers by Sherry A. Weppler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherry A. Weppler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry A. Weppler. The network helps show where Sherry A. Weppler may publish in the future.

Co-authorship network of co-authors of Sherry A. Weppler

This figure shows the co-authorship network connecting the top 25 collaborators of Sherry A. Weppler. A scholar is included among the top collaborators of Sherry A. Weppler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherry A. Weppler. Sherry A. Weppler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Chittaranjan, Suganthi, Svetlana Bortnik, Wieslawa H. Dragowska, et al.. (2014). Autophagy Inhibition Augments the Anticancer Effects of Epirubicin Treatment in Anthracycline-Sensitive and -Resistant Triple-Negative Breast Cancer. Clinical Cancer Research. 20(12). 3159–3173. 130 indexed citations
2.
Dragowska, Wieslawa H., Sherry A. Weppler, Anita I. Kapanen, et al.. (2013). Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer. PLoS ONE. 8(10). e76503–e76503. 91 indexed citations
3.
Verreault, Maïté, et al.. (2013). Combined RNAi-Mediated Suppression of Rictor and EGFR Resulted in Complete Tumor Regression in an Orthotopic Glioblastoma Tumor Model. PLoS ONE. 8(3). e59597–e59597. 25 indexed citations
4.
Dragowska, Wieslawa H., Sherry A. Weppler, Mohammed A. Qadir, et al.. (2011). The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity. BMC Cancer. 11(1). 420–420. 22 indexed citations
5.
Claessens, Tijs, Sherry A. Weppler, Michel van Geel, et al.. (2010). Neuroendocrine carcinoma in a patient with Birt–Hogg–Dubé syndrome. Nature Reviews Urology. 7(10). 583–587. 5 indexed citations
6.
Dubois, Ludwig J., Michaël G. Magagnin, Arjen H.G. Cleven, et al.. (2009). Inhibition of 4E-BP1 Sensitizes U87 Glioblastoma Xenograft Tumors to Irradiation by Decreasing Hypoxia Tolerance. International Journal of Radiation Oncology*Biology*Physics. 73(4). 1219–1227. 31 indexed citations
7.
Weppler, Sherry A., Ludwig J. Dubois, Natasja G. Lieuwes, et al.. (2007). Expression of EGFR variant vIII promotes both radiation resistance and hypoxia tolerance. Radiotherapy and Oncology. 83(3). 333–339. 40 indexed citations
8.
Aerts, Hugo J.W.L., Ludwig J. Dubois, Tilman M. Hackeng, et al.. (2007). Development and evaluation of a cetuximab-based imaging probe to target EGFR and EGFRvIII. Radiotherapy and Oncology. 83(3). 326–332. 23 indexed citations
9.
Weppler, Sherry A., et al.. (2006). Response of U87 glioma xenografts treated with concurrent rapamycin and fractionated radiotherapy: Possible role for thrombosis. Radiotherapy and Oncology. 82(1). 96–104. 37 indexed citations
10.
Koritzinsky, Marianne, Michaël G. Magagnin, Twan van den Beucken, et al.. (2006). Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. The EMBO Journal. 25(5). 1114–1125. 292 indexed citations
11.
Wouters, Bradly G., Sherry A. Weppler, Marianne Koritzinsky, et al.. (2002). Hypoxia as a target for combined modality treatments. European Journal of Cancer. 38(2). 240–257. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edwardine Nodzenski Breakdown of academic impact, for papers by G Migneco Breakdown of academic impact, for papers by Cristovão M. Sousa Breakdown of academic impact, for papers by Shinichi Yabuuchi Breakdown of academic impact, for papers by Trine Bøttzauw Breakdown of academic impact, for papers by Sahithi Pamarthy Breakdown of academic impact, for papers by Arnaud Blomme Breakdown of academic impact, for papers by O. Porta Olivares Breakdown of academic impact, for papers by Catherine Del Vecchio Fitz Breakdown of academic impact, for papers by Bhaswati Sarcar
Rankless by CCL
2026